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Introduction
Ubiquitin, especially monoubiquitin, has been a well-documented 
sorting signal for both endocytosed plasma membrane (PM) 
proteins and intracellular resident proteins traffi  cking from the 
TGN to endosomes or lysosomes (Hicke, 2001). This has been 
extensively studied in yeast, where ubiquitination serves an 
  important sorting signal to determine protein targeting to either 
the lumen or the limiting membrane of the vacuole (lysosome; 
Helliwell et al., 2001; Katzmann et al., 2001; Soetens et al., 
2001; Blondel et al., 2004). The role of ubiquitin in sorting pro-
teins from the Golgi to endosomes/lysosomes in mammalian 
cells is not as clear.
Either blocking ubiquitin modifi  cation or adding a single 
ubiquitin to cargo proteins diverts them away from their normal 
cellular destination. For example, blocking ubiquitination of the 
vacuolar carboxypeptidase S or adding a ubiquitin to the hydro-
lase dipeptidylaminopeptidase B in yeast diverts these proteins 
to the limiting membrane or lumen of the vacuole, respectively 
(Katzmann et al., 2001, 2002). Likewise, the ubiquitination sta-
tus of the yeast GAP1 and Fur4 permeases determines their fate 
during sorting at the Golgi (Blondel et al., 2004; Helliwell et al., 
2001; Soetens et al., 2001). In both yeast and mammalian cells, 
most of the ubiquitinated proteins that reach the vacuole/lyso-
some interior are either PM proteins, which then undergo deg-
radation (Levkowitz et al., 1998; Hicke, 2001; Rocca et al., 
2001), or hydrolytic enzymes activated inside the vacuolar lu-
men (Odorizzi et al., 1998). If proteins are not ubiquitinated, 
they are either recycled back to the PM (Levkowitz et al., 1998) 
or delivered to the limiting membrane of multivesicular bodies 
(MVBs) or the vacuole/lysosome (Katzmann et al., 2001). 
Therefore, mono- or multimonoubiquitination plays a critical 
role in targeting cargo proteins to their proper cellular destina-
tion (Terrell et al., 1998; Shih et al., 2000; Mosesson et al., 
2003), hence deciding their fate (degradation vs. recycling).
The monoubiquitin sorting signal can be recognized and 
transmitted by several proteins involved in both the endocytic 
and biosynthetic pathways through direct physical interaction. 
These proteins often possess ubiquitin-binding motifs/domains 
(“ubiquitin receptors”), such as ubiquitin-interacting motif 
(UIM; Hofmann and Falquet, 2001), GAT (GGA and Tom 
  homologue), UBA, UEV, VHS, and CUE (Hicke et al., 2005). 
The UIMs in epsin and eps15/eps15R play an important role in 
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  internalization and the early stages of endocytosis of PM pro-
teins, such as the EGFR (Oldham et al., 2002; Polo et al., 2002), 
whereas the UIMs of Vps27/Hrs and Hse1/STAM are associ-
ated with sorting function at the early and late endosome 
  (Bilodeau et al., 2002; Raiborg et al., 2002; Shih et al., 2002). 
Interestingly, several UIM-containing endocytic proteins (e.g., 
epsin, eps15, and Hrs) are themselves ubiquitinated outside of 
the UIM sequence itself (Katz et al., 2002; Polo et al., 2002; 
Miller et al., 2004). At least in some cases, this ubiquitination 
appears to involve Nedd4 family members. Nedd4 is a ubiquitin 
ligase comprised of a C2 domain, 3–4 WW domains that bind 
PY motifs (L/PPxY) on target proteins, and a ubiquitin ligase 
Hect domain (Staub and Rotin, 2006). However, it is not yet 
clear how Nedd4 proteins are recruited to these endocytic pro-
teins, which do not possess PY motifs. Moreover, the precise 
role of ubiquitination of these UIM-containing endocytic pro-
teins in cargo sorting and transport is not known.
The Golgi-localized, γ-ear–containing, ADP ribosylation 
factor–binding proteins (GGAs) are primarily associated with 
the TGN, and play a role in lysosomal and endosomal sorting 
(Dell’Angelica et al., 2000; Bonifacino, 2004; Pelham, 2004). 
For example, they sort mannose 6-phosphate receptors from the 
Golgi to the lysosome by binding to the cytoplasmic dileucine 
motifs of the receptor (Puertollano et al., 2001; Zhu et al., 2001; 
Misra et al., 2002). GGA3 was reported to also function as an 
adaptor to sort the internalized EGFR to endosomes  (Puertollano 
and Bonifacino, 2004; Kametaka et al., 2005). In yeast, it was 
shown that GGA binds to the ubiquitinated Gap1 permease, 
  diverting it from the TGN to the vacuole/lysosome (Soetens 
et al., 2001; Scott et al., 2004). In both mammalian and yeast 
cells, ubiquitin was shown to bind to the GAT domain of the 
GGAs (Puertollano and Bonifacino, 2004; Scott et al., 2004; Shiba 
et al., 2004). Thus, monoubiquitin is a universal sorting signal not 
only at the cell surface or in endosomes but also at the Golgi.
Lysosomal-associated protein transmembrane 5 (LAPTM5) 
is a multispanning transmembrane protein that resides in the 
late endosome/lysosome and is expressed primarily in hemato-
poietic cells (Adra et al., 1996; Scott et al., 1996). We isolated 
LAPTM5 in a screen for Nedd4-WW domain–interacting 
  proteins, and detected three PY motifs and a UIM in that 
protein (unpublished data). The function of this lysosomal pro-
tein is so far unknown. LAPTM5 is related to LAPTM4 (also 
Figure 1.  Schematic representation of LAPTM5, 
Nedd4, and GGA3, and their mutants used 
in the study. (A) WT LAPTM5 showing its pre-
dicted TM domains (TM), the three PY motifs 
(PY1, PY2, PY3), the UIM (also depicted in the 
boxed sequence at the bottom), and the 
C-terminal SxV (putative PDZ-binding) motif. The 
various mutants of LAPTM5 used in the study 
are shown as well. (B) Nedd4 (Nedd4-1) and 
its catalytically inactive Nedd4(CS) bearing 
a Cys®Ser mutation in the Hect domain. 
(C) GGA3 and its L276A mutant in the GAT 
domain that cannot bind ubiquitin. NEDD4 AND GGA3 SORT LAPTM5 TO LYSOSOMES • PAK ET AL. 633
known as MTP), a lysosomal protein that is widely expressed in 
many cell types (Hogue et al., 1996, 1999; Cabrita et al., 1999). 
LAPTM4 was shown to confer multidrug resistance by trans-
porting a range of small molecules, including nucleosides, 
  nucleobase analogues, antibiotics, anthracyclines, ionophores, 
and steroid hormones (Cabrita et al., 1999; Hogue et al., 1999). 
It is believed to function in sequestration of these small mole-
cules into the lysosome, thus, protecting the cell from their 
harmful effects. LAPTM4 has two splice isoforms, LAPTM4α 
and -β (Hogue et al., 2002). LAPTM4α was shown to possess 
two Tyr-based motifs (YxxΦ) that are responsible for its local-
ization to the lysosome (Hogue et al., 2002). How LAPTM5 is 
sorted to the lysosome has not been elucidated and was the fo-
cus of our studies.
We show that LAPTM5 is sorted from the Golgi to the 
lysosome by association via its PY motifs with Nedd4. The 
Nedd4–LAPTM5 complex recruits GGA3, and ubiquitinated 
GGA3 binds the UIM of LAPTM5. The Nedd4-triggered 
LAPTM5–GGA3 association then promotes translocation of 
LAPTM5 from the Golgi to the lysosome. Interestingly, this 
translocation does not require LAPTM5 ubiquitination.
Results
Interaction of LAPTM5 with Nedd4 
is necessary for its sorting to the lysosomes
Our earlier work identifi  ed LAPTM5 in a screen for proteins 
that interact with the second WW domain of Nedd4-1 (Nedd4; 
unpublished data). The intracellular domains of LAPTM5 con-
tain three PY (L/PPxY) motifs; an LPAY motif located between 
transmembrane (TM) domains 3 and 4, and LPSY and PPPY 
motifs in the cytoplasmic C terminus (Fig. 1). We also identifi  ed 
a UIM in this protein (Fig. 1). The presence of the three PY mo-
tifs in LAPTM5, our identifi  cation of Nedd4 as a binding part-
ner for LAPTM5, and the observation that LAPTM5 is localized 
to late endosomes (LEs) or lysosome (Adra et al., 1996), 
prompted us to investigate whether Nedd4 may be involved in 
sorting of LAPTM5 to the LE/lysosomes.
To test whether these three PY motifs are responsible for 
Nedd4 binding, all three Tyr residues in the PY motifs were 
mutated to alanines (3YA; Fig. 1), and wild-type (WT) LAPTM5 
or its 3YA mutant were tested for binding to a catalytically 
  in  active Nedd4(CS) in a coimmunoprecipitation (coIP) assay. 
A catalytically inactive Nedd4(CS) was used to prevent a possi-
ble degradation of LAPTM5 in the event that it is a substrate for 
Nedd4. As shown in Fig. 2 A (top), after ectopic expression in 
human embryonic kidney 293T (HEK293T) cells, LAPTM5(WT) 
was able to coIP with Nedd4(CS), and this binding was lost in 
the LAPTM5-3YA mutant. Of the three PY motifs, the third one 
(PY3) appears most important for binding to Nedd4, with the 
fi  rst PY motif (PY1), but not PY2, contributing to the interaction 
as well (Fig. S1 A, available at http://www.jcb.org/cgi/content/
full/jcb.200603001/DC1). These results demonstrate that Nedd4 
binds to the PY motifs of LAPTM5.
To examine whether Nedd4 binding leads to ubiquitina-
tion of LAPTM5, lysates from HEK293T cells expressing HA-
tagged LAPTM5 together with His(x8)-tagged ubiquitin were 
Figure 2.  Interactions between Nedd4 and LAPTM5 and Nedd4-
  mediated ubiquitination of LAPTM5. (A) coIP of WT, or the 3YA mutant of 
LAPTM5 (3YA), with Nedd4. T7-tagged Nedd4 was immunoprecipitated 
from HEK293T cells coexpressing HA-tagged LAPTM5 and the precipitate 
immunoblotted with anti-HA antibodies to detect coimmunoprecipitated 
LAPTM5. (B) Ubiquitination of LAPTM5 is dependent on the presence of 
its PY motifs (Nedd4 binding sites). HEK293T cells were cotransfected 
with HA-LAPTM5 (WT or the 3YA mutant) and His-tagged ubiquitin 
(His-Ub), and then the cells were lysed and the lysate was boiled in SDS. 
Ubiquitinated (histidinated) proteins were then precipitated with Ni–
  Agarose
2+ (Ni–Agarose) beads and blotted with anti-HA antibodies to 
  detect ubiquitinated LAPTM5. (C) LAPTM5 ubiquitination is mediated 
by Nedd4. The experiment was performed as in B, only His-Ub and 
HA-LAPTM5 were cotransfected with either WT or a catalytically inactive 
Nedd4(CS). Bottom sections of all blots represent lysate controls for 
protein expression.JCB • VOLUME 175 • NUMBER 4 • 2006  634
boiled in SDS (to dissociate other putative interacting proteins), 
precipitated with Ni
2+–Agarose beads (which bind His), and 
subjected to immunoblotting with anti-HA antibodies to detect 
ubiquitinated LAPTM5. As seen in Fig. 2 B, LAPTM5(WT) was 
ubiquitinated in cells (that express endogenous Nedd4), and this 
ubiquitination was dependent on the presence of its PY motifs, 
as it was eliminated in the LAPTM5-3YA mutant. In agreement 
with the binding data (Fig. S1 A), PY3 appears most important 
for LAPTM5 ubiquitination (Fig. S1 B). These results suggest 
that LAPTM5 ubiquitination is mediated by Nedd4. Indeed, 
overexpression of a catalytically inactive Nedd4(CS), together 
with LAPTM5, inhibited this ubiquitination (Fig. 2 C), likely 
Figure 3.  Golgi-to-lysosome sorting of LAPTM5 is dependent on its PY motifs. (A–C) Immunoﬂ  uorescent (confocal) analysis of Golgi versus lysosomal 
  localization of LAPTM5 and its 3YA mutant; HEK293T cells were transfected with DsRed-LAPTM5(WT) or the DsRed-LAPTM5(3YA) mutant and costained 
with either the Golgi marker giantin (green) or the lysosomal marker LAMP1 (green). 14 h after transfection (A), 18 h after transfection (B), and 24 h after 
transfection (C). Concanavalin A (ConA) was used as a marker for the plasma membrane (blue). Images represent confocal analysis. (D and E) ImmunoEM 
analysis of lysosomal or Golgi localization of WT-LAPTM5 and its 3YA mutant expressed in HEK293T cells. (D) Colocalization of HA-tagged WT LAPTM5 
(6-nm gold particles, yellow arrow) with the LE/lysosomal marker LAMP2 (10-nm gold particles, white arrow). (E) Colocalization of HA-tagged LAPTM5-
3YA mutant (6-nm gold particles, yellow arrow) with the Golgi markers giantin or furin (10-nm gold particles, white arrow). Bars: (A–C) 5 μm; (D and E) 
100 nm.NEDD4 AND GGA3 SORT LAPTM5 TO LYSOSOMES • PAK ET AL. 635
in a dominant-negative fashion. Most of the LAPTM5 in these 
assays appeared to be either mono- or diubiquitinated. Collec-
tively, these results indicate that Nedd4 is likely the ubiquitin 
ligase that ubiquitinates LAPTM5.
Because LAPTM5 was previously shown to localize to 
lysosomes (Adra et al., 1996), we next tested whether this lo-
calization is dependent on Nedd4-mediated interaction with 
LAPTM5. Thus, DsRed-tagged LAPTM5(WT) was transfected 
into HEK293T cells, and its localization was assessed by confo-
cal microscopy. As seen in Fig. 3 A, at 14 h after transfection, 
LAPTM5(WT) was localized to the Golgi, as determined by co-
localization with giantin. By 18 h, some of it has translocated 
to vesicles that costain with the lysosomal marker LAMP1 (Fig. 
3 B), and by 24 h, most of it was localized to the lysosome (Fig. 
3 C, Table I, and Table S1, available at http://www.jcb.org/cgi/
content/full/jcb.200603001/DC1). This was further validated by 
immunoEM analysis (Fig. 3 D), which demonstrates localization 
of LAPTM5 in LAMP2-containing vesicles (lysosomes). In con-
trast, the mutant LAPTM5-3YA, which cannot bind Nedd4, was 
retained in the Golgi and appeared unable to translocate to the 
lysosome even after 24 (Fig. 3, A–C and E, Table I, and Table 
S1) or 48 h (not depicted) after transfection. It was also not lo-
calized to EEA1- (early endosomes), Hrs- (sorting endosomes), 
or Rab11 (recycling endosome)-containing vesicles (Table I and 
Fig. S2). The ability of the LAPTM5-3YA mutant to localize 
early after transfection to the Golgi suggests that this mutant is 
properly folded and able to enter the Golgi from the ER (Fig. 3 E, 
immunoEM), much like the WT LAPTM5. Rather, it is the sort-
ing step from the Golgi to the lysosome that is defective in the 
3YA mutant, most likely caused by its inability to bind Nedd4.
To further test for the role of Nedd4 in the Golgi to lyso-
some sorting of LAPTM5, we knocked down endogenous 
Nedd4 in HEK293T cells with RNAi (Fig. 4 A). As seen in Fig. 
4 B, Table I, and Table S1, knockdown of endogenous Nedd4 
resulted in retention of LAPTM5 in the Golgi. Interestingly, this 
impaired Golgi to lysosomal sorting was observed despite nor-
mal expression of endogenous Nedd4-2, which was unaffected 
by our knockdown of endogenous Nedd4 (Nedd4-1; Fig. 4 A). 
This suggest that Nedd4, rather than Nedd4-2, is involved in ly-
sosomal targeting of LAPTM5.
 Collectively, these results suggest that Nedd4 binding to 
LAPTM5 is necessary for sorting of LAPTM5 from the Golgi 
to the lysosome.
Ubiquitination of LAPTM5 
is not necessary for translocation 
of LAPTM5 to the lysosomes
Ubiquitination has been well documented as a sorting signal for 
delivery of biosynthetic proteins to the lumen of the yeast vacu-
ole (Katzmann et al., 2002). Its role in sorting mammalian 
transmembrane proteins is less clear. Because we found that 
Nedd4 binding to LAPTM5 is required for its sorting to the lys-
osome (Fig. 3), and LAPTM5 is ubiquitinated by Nedd4 (Fig. 2), 
we next tested if LAPTM5 ubiquitination is involved in its 
  sorting to the lysosome. We, thus, generated a mutant LAPTM5 
with all of its 10 cytoplasmic Lys residues mutated to Arg 
(10KR; Fig. 1) to render it ubiquitination-impaired. The ubiqui-
tination status of this mutant was then analyzed after its cotrans-
fection with His-tagged ubiquitin, as described in Fig. 2. As 
expected, the LAPTM5-10KR mutant failed to become ubiqui-
tinated (Fig. 5 A), although it was still able to bind Nedd4 (Fig. 
5 B) because its PY motifs are intact. 
To analyze the requirement of LAPTM5 ubiquitination for 
its sorting from the Golgi to the lysosome, we tested the ability 
of the ubiquitination-impaired LAPTM5-10KR mutant to trans-
locate to the lysosome from the Golgi. We fi  rst verifi  ed that 
LAPTM5-10KR fused to DsRed is not itself ubiquitinated be-
cause of the added DsRed moiety (Fig. 5 C), and then we used it 
for immunolocalization studies. As seen in Fig. 5 D and quanti-
fi  ed in Tables I and S1, most of the LAPTM5-10KR mutant was 
localized to the Golgi at 18 h after transfection and to the lyso-
somes at 24 h after transfection, quite similar (although not iden-
tical) to WT LAPTM5 (Fig. 3 and Table I). Moreover, HA-tagged 
LAPTM5-10KR was also able to sort to the lysosome (Fig. S3, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200603001/DC1). 
These results suggest that ubiquitination of LAPTM5 is not 
necessary for its translocation to the lysosome.
Table I. Quantitative analysis of colocalization of LAPTM5 with 
organelle markers
Cell type Organelle Pearson’s coefﬁ  cient
HEK293T
  WT Lysosomes 0.819, r(20), P < 0.01
Golgi 0.296, r(20), P > 0.10
  3YA Lysosomes 0.241, r(20), P > 0.10
Golgi 0.809, r(20), P < 0.01
Recycling e 0.118, r(15), P > 0.10
Sorting e 0.103, r(15), P > 0.10
Early e 0.104, r(15), P > 0.10
  10KR Lysosomes 0.733, r(20), P < 0.01
Golgi 0.419, r(20), P > 0.05
Recycling e 0.151, r(15), P > 0.10
Sorting e 0.165, r(15), P > 0.10
Early e 0.157, r(15), P > 0.10
  UIMm Lysosomes 0.410, r(20), P > 0.05
Golgi 0.680, r(20), P < 0.01
Recycling e 0.165, r(15), P > 0.10
Sorting e 0.125, r(15), P > 0.10
Early e 0.133, r(15), P > 0.10
 WT  + Nedd4 RNAi Lysosomes 0.359, r(20), P > 0.10
Golgi 0.783, r(20), P < 0.01
 WT  + GGA3 RNAi Lysosomes 0.318, r(20), P > 0.10
Golgi 0.748, r(20), P < 0.01
DC2.4
  WT Lysosomes 0.712, r(20), P < 0.01
Golgi 0.218, r(20), P > 0.10
  3YA Lysosomes 0.398, r(25), P < 0.05
Golgi 0.453, r(25), P < 0.05
Recycling E 0.165, r(15), P > 0.10
Sorting E 0.167, r(15), P > 0.10
Early E 0.162, r(15), P > 0.10
Quantiﬁ  cation on individual randomly selected dsRed-LAPTM5–transfected cells 
was performed using LSM510 and Volocity 3.7.0. The extent of colocalization 
is indicated as Pearson’s coefﬁ  cient, corresponding to the degrees of freedom (r) 
and level of signiﬁ  cance (P). The following markers of organelles were used in 
the analysis: LAMP1 (lysosomes), giantin (Golgi), Rab11 (recycling endosomes), 
Hrs (sorting endosomes), and EEA1 (early endosomes).JCB • VOLUME 175 • NUMBER 4 • 2006  636
Together, these data suggest that binding to Nedd4, rather 
than ubiquitination, may function as a lysosomal sorting signal 
for LAPTM5.
GGA3 interacts with LAPTM5 
in the presence of Nedd4
We next tested the possibility that binding of Nedd4 to 
LAPTM5 may unravel an as yet unidentifi  ed sorting signal 
within LAPTM5, permitting lysosomal targeting. Because the 
3YA mutant of LAPTM5, which failed to bind to Nedd4, was 
retained in the Golgi, we focused our studies on Golgi sorting.
The GGA proteins bind mannose 6-phosphate receptors 
at the Golgi and play an essential role in lysosomal sorting 
  (Bonifacino, 2004; Pelham, 2004). Therefore, we fi  rst tested 
whether GGA3 could bind to LAPTM5. Cell lysates expressing 
either T7-tagged Nedd4 alone or HA-tagged LAPTM5 were 
immunoprecipitated and subjected to immunoblotting with anti-
GGA3 antibody to detect if endogenous GGA3 could coimmuno-
precipitate in the complex. As shown in Fig. 6 A, neither protein 
alone could bind GGA3 (lanes 2 and 3). However, GGA3 was 
immunoprecipitated in a complex with LAPTM5(WT) and 
Nedd4(WT), but only poorly with the catalytically inactive 
Nedd4(CS; Fig. 6 A, lane 4 and 5). Furthermore, only a higher 
form of endogenous GGA3 was found in the complex, although 
a doublet is seen in the lysate (Fig. 6 A, lane 6). Immunoprecipi-
tating endogenous GGA3 followed by immunoblotting with 
anti-ubiquitin antibody demonstrated that this upper band was 
ubiquitinated GGA3 (not depicted), in accord with earlier work, 
which reported that GGA3 undergoes monoubiquitination 
(Shiba et al., 2004). Collectively, these data suggest that GGA3 
is found in a complex with LAPTM5 and Nedd4 (but not 
Nedd4[CS]), and that GGA3 in this complex is most likely the 
ubiquitinated form of the protein.
The GGA proteins contain various domains that are in-
volved in protein–protein interactions (Fig. 1; Bonifacino, 2004; 
Pelham, 2004). Recently, the GAT domain of GGA3 was reported 
to bind ubiquitin (Puertollano and Bonifacino, 2004; Shiba et al., 
2004). Thus, we tested whether ubiquitinated LAPTM5 can 
bind to the GGA3-GAT domain. We fi  rst confi  rmed that endoge-
nous GGA3 binds ubiquitin by demonstrating that G protein–
  conjugated ubiquitin (prot-G-Ub) is able to precipitate GGA3 
(Fig. 6 B). To confi  rm that the GGA3-GAT domain is responsible 
for ubiquitin binding, we expressed wt and GAT domain mutant 
GGA3 (GGA3-L276A) in HEK293T cells and repeated the pre-
cipitation assay with prot-G-Ub. As seen in Fig. 6 C, GGA3-L276A 
was no longer able to bind ubiquitin, as previously reported 
(Puertollano and Bonifacino, 2004; Shiba et al., 2004). However, 
it is interesting that more of the lower band of GGA3 binds to 
ubiquitin (Fig. 6 C), which is different from the form that is in a 
complex with LAPTM5 and Nedd4 (Fig. 6 A).
To understand how GGA3 forms a complex with LAPTM5 
and Nedd4, we expressed WT and the GGA3-L276A mutant, 
together with a combination of WT and mutant LAPTM5 and 
Nedd4, and subjected the lysate to coIP with LAPTM5. If ubiq-
uitinated LAPTM5 binds to the GAT domain of GGA3, only 
WT GGA3 should complex with LAPTM5 and Nedd4. How-
ever, both WT GGA3 and the GGA3-L276A mutant were able 
to bind to the Nedd4–LAPTM5 complex (Fig. 6 D), suggesting 
that GAT function as a ubiquitin-binding motif is not necessary 
for the association with this complex. Furthermore, it suggests 
that ubiquitination of LAPTM5 may not contribute to the for-
mation of the complex. This is consistent with our data (Fig. 5 
and Table I) that show effi  cient sorting of LAPTM5-10KR to 
the lysosome.
Because GGA3 can coprecipitate with the Nedd4–
LAPTM5 complex, we tested the possibility that GGA3 itself 
Figure 4. Knockdown of Nedd4 inhibits 
Golgi-to-lysosome sorting of LAPTM5. (A) Ex-
pression of GFP-Nedd4-1-RNAi (Nedd4-RNAi) 
in HEK293T cells leads to knockdown of endog-
enous Nedd4-1 (left), but not Nedd4-2 (right). 
Afﬁ  nity-pure antibodies that preferentially rec-
ognize Nedd4-1 (anti-Hect antibodies, left) or 
Nedd4-2 (right) were used to detect the re-
spective Nedd4 proteins after transfection with 
pSUPER-GFP-Nedd4-1-RNAi (Nedd4-1-RNAi), 
pSUPER-GFP (vector), pSUPER-GFP–nonspeciﬁ  c 
control (NS-control), or Nedd4-1. Actin controls 
are shown as well. (B) Cells coexpressing GFP-
Nedd4-RNAi (white) and DsRed-LAPTM5 (red) 
were costained with anti-giantin (green) or 
-LAMP1 (green) antibodies 24 h after transfec-
tion of LAPTM5. GFP-Nedd4-RNAi (in pSUPER 
vector) was transfected 48 h before the trans-
fection of LAPTM5, to ensure sufﬁ  cient  time 
for knockdown of endogenous Nedd4 (i.e., 
Nedd4-1). Bar, 5 μm.NEDD4 AND GGA3 SORT LAPTM5 TO LYSOSOMES • PAK ET AL. 637
may become ubiquitinated by Nedd4. Fig. 6 E demonstrates that, 
indeed, endogenous GGA3 can become ubiquitinated by coex-
pressed Nedd4, but not by the catalytically inactive Nedd4(CS).
LAPTM5 has a UIM that is responsible 
for GGA3 binding and lysosomal targeting
As mentioned above, only the higher form of GGA3 was im-
munoprecipitated in a complex with LAPTM5 and Nedd4 (Fig. 
6 A), suggesting that GGA3 in that complex is most likely the 
ubiquitinated form. LAPTM5 contains a putative UIM at its C 
terminus (Fig. 1). To test if this putative UIM binds ubiquitin 
and ubiquitinated GGA3, cell lysates expressing either HA-
tagged LAPTM5 or T7-tagged Nedd4 were precipitated with 
prot-G-Ub. Nedd4 did not bind to this immobilized ubiquitin 
(Fig. 7 B). However, LAPTM5 was able to bind ubiquitin (Fig. 
7, A–C), binding that was not seen in its 3YA mutant (Fig. 7, A 
and C). These results suggest that binding of Nedd4 to LAPTM5 
affects the ability of LAPTM5 to bind ubiquitin. To further test 
this, we incubated cell lysates expressing LAPTM5 together with 
either WT or catalytically inactive Nedd4(CS) with prot-G-Ub, 
and immunoblotted the precipitate with antibodies to LAPTM5 
or Nedd4 (i.e., to their tags). Fig. 7 B (top) shows that ubiquitin 
was able to bind to LAPTM5 only in the presence of WT Nedd4, 
but not Nedd4(CS). This suggests that active Nedd4 is needed 
to allow binding of LAPTM5 to ubiquitin.
We next tested the role of the LAPTM5-UIM in ubiqui-
tin binding, as well as the dependency of binding on the levels 
of Nedd4 expressed in cells. As shown in Fig. 7 C, LAPTM5 
was able to bind ubiquitin substantially better when Nedd4 was 
overexpressed (compare lane 2 to 7). Mutant LAPTM5 trun-
cated at amino acid 248 at the C-tail (∆C, Fig. 1) almost com-
pletely lost its ubiquitin-binding capacity (Fig. 7 C, lanes 5 and 10), 
suggesting that the UIM, which resides in this region, may be 
important for binding to ubiquitin. Because this C-terminal re-
gion also contains a potential PDZ-binding sequence (SxV), 
we made two independent mutants of LAPTM5; a UIM mu-
tant (UIMm; Fig. 1) known to be defective in ubiquitin binding 
(Shekhtman and Cowburn, 2002), and a Val to Ala substitution 
of the last residue of LAPTM5 (LAPTM5-VA; Fig. 1), which 
should preclude binding to PDZ domains. We then tested the 
Figure 5.  Loss of LAPTM5 ubiquitination does not block its lysosomal sorting. (A) HA-tagged LAPTM5 or LAPTM5(10KR) were coexpressed with His-Ub 
in HEK293T cells. Cells were lysed, and then boiled lysates were incubated with Ni
2+–Agarose beads to precipitate ubiquitinated (Histidinated) proteins, 
and immunoblotted with HA antibodies to detect ubiquitinated LAPTM5 or its 10KR mutant, as described in Fig. 2. The majority of WT LAPTM5 appears 
as a diubiquitinated species. (B) T7-Nedd4 and HA-LAPTM5 (WT or the 10KR mutant) were cotransfected into HEK293T cells and lysates immunoprecipi-
tated with T7 antibodies (Nedd4), and blotted with HA antibodies (LAPTM5) to detect coIP of LAPTM5 with Nedd4. A and B (bottom) represent lysate con-
trols. (C) DsRed-LAPTM5(10KR) is not ubiquitinated; the experiment was performed as in A, except that transfected LAPTM5 or its mutants were tagged with 
DsRed instead of HA. (D) Cells expressing DsRed-LAPTM5 (WT or the 10KR mutant, red) were stained with anti-giantin (green) or -LAMP1 (green) antibod-
ies, as in Fig. 3, to follow Golgi to lysosomal sorting of the LAPTM5-10KR mutant. Images are confocal pictures. The plasma membrane is stained with 
ConA (blue). Bar, 5 μm.JCB • VOLUME 175 • NUMBER 4 • 2006  638
ability of these mutants to bind ubiquitin. Our results show 
that the VA mutant had a slightly reduced ubiquitin-binding 
ability (Fig. 7 C, lane 6 and 11). The UIMm mutant, however, 
revealed a dramatic decrease in ubiquitin binding (Fig. 7 C), 
suggesting that the UIM of LAPTM5 plays a key role in bind-
ing ubiquitin.
As detailed above, we observed that the LAPTM5-10KR 
and -3YA mutants, both unable to become ubiquitinated, 
showed a different pattern of subcellular distribution 24 h   after 
transfection; the 10KR mutant was primarily translocated to the 
lysosome (similar to WT LAPTM5), whereas the PY motif 
mutant was retained in the Golgi (Figs. 3 and 5). We thus tested 
whether these two mutants showed a difference in GGA3   binding. 
Cell lysates expressing Nedd4 together with a combination of 
either WT or mutant LAPTM5 were immunoprecipitated with 
Nedd4 antibodies and subjected to immunoblotting with anti-
GGA3 antibody to detect if endogenous GGA3 coIPs with 
the complex. As seen in Fig. 7 D, the LAPTM5-10KR mutant 
was able to complex with GGA3 in the presence of Nedd4, 
much like WT LAPTM5 (Fig. 7 D, lane 1 and 4). However, 
the LAPTM5-3YA mutant was unable to bind GGA3 (Fig. 7 D, 
lane 2), suggesting that interactions with Nedd4, rather than 
the ubiquitination status of LAPTM5, is important for GGA3 
binding. Furthermore, the UIM of LAPTM5 was responsible 
for GGA3 interaction with the complex because GGA3 binding 
was completely abolished in the UIM mutant, LAPTM5-UIMm 
(Fig. 7 D, lane 3). Importantly, this same UIM mutant that can-
not bind ubiquitin or GGA3 was also unable to sort LAPTM5 
from the Golgi to the lysosome (Fig. 8 A, Table I, and Table S1). 
Because the mutations in the UIM were close to the second PY 
motif (LPsY) of LAPTM5, we tested the ability of this UIMm 
mutant to bind Nedd4. As seen in Fig. 7 E, the UIMm mutant 
was still able to bind Nedd4, similar to WT LAPTM5 (lane 2 
and 4), suggesting that Nedd4 binding to LAPTM5 does not 
require the UIM. Collectively, these data suggest that binding 
of Nedd4 to LAPTM5 promotes the UIM of LAPTM5 to bind 
ubiquitinated GGA3. This then allows LAPTM5 to translocate 
from the Golgi to the lysosome.
Figure 6.  GGA3 associates with the Nedd4–
LAPTM5 complex and can be ubiquitinated by 
Nedd4. (A) Lysates of HEK293T cells express-
ing HA-tagged LAPTM5 and T7-tagged Nedd4 
(WT or CS) were immuno  precipitated with HA 
(LAPTM5) and blotted with GGA3 antibodies. 
Note the CoIP of GGA3 with LAPTM5 only 
when active Nedd4 is present. (B) HEK293T 
cell lysate (which expresses endogenous 
GGA3) was incubated with ubiquitin immobi-
lized on protein G beads (pro-G-Ub), the 
beads were washed, and GGA3 was bound 
to the immobilized ubiquitin detected with anti-
GGA3 antibodies. (C) As in B, only cells were 
transfected with Myc-tagged WT or the L276A 
mutant of GGA3 (which cannot bind ubiqui-
tin), and binding to pro-G-Ub was subsequently 
tested. Note in B and C that the lower band of 
GGA3 (likely nonubiquitinated) is the one that 
more strongly binds ubiquitin. (D) Cells were 
transfected with T7-Nedd4 (WT or CS mutant), 
Myc-GGA3 (WT or the L276A mutant that can-
not bind ubiquitin), and HA-LAPTM5, and their 
lysate was subjected to IP with HA (LAPTM5) 
antibodies and immuno  blotting for Myc 
(GGA3). (E) Nedd4 is able to ubiquitinate 
GGA3; HEK293T cells were cotransfected (or 
not) with LAPTM5, His-Ub, T7-Nedd4(WT), or 
T7-Nedd4(CS). Lysates of these cells were in-
cubated with Ni
2+–Agarose beads to precipi-
tate histidinated (ubiquitinated) proteins, and 
with proteins immunoblotted with anti-GGA3 
antibodies, to detect ubiquitination of endoge-
nous GGA3. Bottom portions of all blots repre-
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GGA3 is required for LAPTM5 
translocation from the Golgi to lysosome
The ability of the LAPTM5-UIM to bind ubiquitinated GGA3 
(Figs. 6 and 7), and the inability of the LAPTM5-UIMm 
  mutant (which cannot bind ubiquitinated GGA3) to translo-
cate to the lysosome (Fig. 8 A), suggest that GGA3 may be 
  responsible for LAPTM5 sorting and translocation. To test 
this, RNAi for GGA3 was used to knockdown endogenous 
GGA3 in HEK293T cells cotransfected with LAPTM5 (and 
expressing endogenous Nedd4). As seen in Fig. 8 B (ii and iii) 
and Tables I, and S1, knockdown of GGA3 led to a substantial 
retention of LAPTM5 in the Golgi and impairment of lyso-
somal sorting.
To further substantiate these results, we performed 
immunoEM analysis to test for colocalization of LAPTM5 
with GGA3. As seen in Fig. 8 B (i), LAPTM5 and GGA3 
are detected together in vesicles that emanate from the TGN 
and lysosomes.
Figure 7.  LAPTM5 binds ubiquitin and GGA3 via its UIM, and active Nedd4 is required for this binding. (A) LAPTM5 (WT or the 3YA mutant) was trans-
fected into HEK293T cells and lysates incubated with pro-G-Ub to test for its ability to bind ubiquitin, as in Fig 6. (B) WT-LAPTM5 was transfected with WT 
or catalytically inactive Nedd4(CS) and lysate incubated with pro-G-Ub, as in A. (C) WT or the indicated mutants of LAPTM5 were transfected in the pres-
ence or absence of cotransfected WT Nedd4 and cell lysate incubated with pro-G-Ub to detect binding of the mutants to ubiquitin. (D) WT-Nedd4 and the 
indicated mutants of LAPTM5 were transfected into cells and the coprecipitation of endogenous GGA3 with the complex analyzed by immunoblotting with 
anti-GGA3 antibodies. (E) WT or the indicated mutants of LAPTM5 were cotransfected with catalytically inactive Nedd4(CS), Nedd4(CS) immunoprecipitated 
from cell lysates and coimmunoprecipitated LAPTM5, or its mutants analyzed by immunoblotting with anti-HA antibodies. Bottom portions of all blots repre-
sent lysate controls for protein expression. JCB • VOLUME 175 • NUMBER 4 • 2006  640
Golgi to lysosome translocation 
of LAPTM5 in dendritic DC2.4 cells
The aforementioned studies were performed in HEK293T cells. 
Although these cells express endogenous Nedd4 and GGA3, 
they do not express endogenous LAPTM5, which is primarily 
a hematopoietic protein. To ensure that the Nedd4/GGA3-
  dependent sorting of LAPTM5 from the Golgi to the lysosome 
was not an artifact of ectopic expression of LAPTM5 in HEK293T 
cells, we tested this sorting in DC2.4 cells, a cell line derived 
from dendritic cells of the immune system (Shen et al., 1997). As 
seen in Fig. S4 (available at http://www.jcb.org/cgi/content/full/
jcb.200603001/DC1), DC2.4 cells express small amounts of 
  endogenous LAPTM5. They also express endogenous Nedd4 
  (unpublished data). We next tested Golgi to lysosomal transport 
in these cells after transfection of DsRed-tagged WT or the 3YA 
mutant of LAPTM5. Fig. 9 B demonstrates that WT LAPTM5 
expressed in DC2.4 cells is sorted from the Golgi to the lyso-
some, as seen in HEK293T cells. This is also validated by demon-
strating colocalization of LAPTM5 with LAMP1 at the membrane 
of lysosomes using immunoEM (Fig. 9 A, i). In contrast, this 
sorting is attenuated in mutant LAPTM5 that cannot bind Nedd4 
(the 3YA mutant); by 24 h after transfection, the proportion of 
cells translocated from the Golgi to the lysosome was much 
greater in the WT relative to the 3YA mutant ( Tables I and S1). 
These results suggest that, much like our observation with 
HEK293T cells, lysosomal sorting of LAPTM5 is also seen in 
dendritic cells that normally express endogenous LAPTM5, and 
this sorting likely involves Nedd4 binding as well. Moreover, the 
segregation of LAPTM5 to GGA3-containing TGN/vesicles and 
MVBs is also seen in the DC2.4 cells (Fig. 9 A, ii).
Discussion
In this paper, we demonstrate that the transmembrane lysosomal 
protein LAPTM5 is sorted from the Golgi to the lysosome with 
the aid of Nedd4 and GGA3, a process not requiring LAPTM5 
ubiquitination. We propose that LAPTM5, Nedd4, and GGA3 
form a complex, whereby ubiquitinated GGA3 binds the UIM of 
Figure 8.  The LAPTM5-UIM and GGA3 are re-
quired for Golgi-to-lysosome sorting of LAPTM5. 
(A) HEK293T cells were transfected with the 
UIM mutant DsRed-LAPTM5-UIMm (red), and 
its localization to the Golgi and lysosome 18 
and 24 h after transfection was analyzed by 
staining with giantin or LAMP1, respectively 
(green). The PM is marked with ConA (blue) 
staining. (B; i) ImmunoEM analysis reveals co-
localization of LAPTM5 (6-nm gold particles, 
yellow arrow) and endogenous GGA3 (10-nm 
gold particles, black arrow) in what appears 
to be a lysosome (left) and vesicles (right). 
(ii) Expression of GFP-tagged GGA3-RNAi in 
HEK293T cells leads to knockdown of endog-
enous GGA3. GGA3 antibodies were used 
to detect knockdown of GGA3 after (or not) 
transfection of pSUPER-GFP (vector), pSUPER-
GFP–scrambled sequence (scrambled), and 
pSUPER-GFP-GGA3-RNAi (GGA3-RNAi). Actin 
controls are shown as well. (iii) Cells coexpress-
ing GFP-GGA3-RNAi (white) and DsRed–
LAPTM5 (red) were stained with anti-giantin 
(green) or anti-LAMP1 (green) antibodies 24 h 
after transfection of LAPTM5. GFP-GGA3-RNAi 
was transfected twice (at 0 and 48 h), followed 
by transfection with DsRed–LAPTM5 24 h later. 
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LAPTM5, facilitating transport of LAPTM5 from the Golgi to 
lysosomes (Fig. 10). It is possible that Nedd4 dissociates from 
this complex once GGA3 is ubiquitinated (possibly by Nedd4) 
and able to bind LAPTM5, allowing the GGA3–LAPTM5 com-
plex to be sorted into GGA3-containing vesicles that ultimately 
arrive at the MVBs/lysosomes (Fig. 10).
LAPTM5 and LAPTM4α and -β belong to a family of ly-
sosomal membrane proteins (Adra et al., 1996; Hogue et al., 
2002). Although the ubiquitously expressed LAPTM4 proteins 
are able to transport small molecules, such as nucleosides, into 
the lysosome (Hogue et al., 1996, 1999), the function of the 
  hematopoietic-expressed LAPTM5 is not yet known. Moreover, 
Figure 9.  LAPTM5 expressed in dendritic DC2.4 cells is also sorted from the Golgi to the lysosome in a PY motif–dependent manner. (A; i) ImmunoEM anal-
ysis reveals colocalization of HA-tagged LAPTM5 (6-nm gold particles, yellow arrow) with LAMP1 (15-nm gold particles, white arrow)-containing vesicles 
(LE/lysosomes) in DC2.4 cells. (ii) ImmunoEM analysis in DC2.4 cells demonstrates colocalization of HA-tagged LAPTM5 (6-nm gold particles, yellow 
arrow) with endogenous GGA3 (10-nm gold particles, black arrow) in a vesicle and in MVBs. (B and C) DC2.4 cells were transfected with DsRed-WT-LAPTM5 
(B, red) or DsRed-LAPTM5-3YA mutant (C, red), and cells were immunostained with anti-giantin or LAMP1 antibodies (green) to detect Golgi to lysosomal 
sorting at the indicated times after transfection. Bars: (A, i) 100 nm; (A, ii) 200 nm; (B and C) 5 μm.JCB • VOLUME 175 • NUMBER 4 • 2006  642
the two family members (LAPTM4 and LAPTM5) may use dif-
ferent sorting signals for lysosomal targeting; LAPTM4α and 
-β have two Tyr-based sorting signals (YxxΦ) at their C termini, 
which, together with a di-Leu motif, are responsible for lyso-
somal targeting (Hogue et al., 2002). This is similar to other 
lysosome-associated membrane proteins, in which Tyr-based or 
di-Leu sorting signals were shown to interact with adaptor pro-
tein complexes (AP-1, -3, and -4; Huizing et al., 2001; Janvier 
et al., 2003; Janvier and Bonifacino, 2005; Theos et al., 2005). 
As we show, LAPTM5 has adapted a different sorting strategy; 
it utilizes its PY motifs (which bind Nedd4-WW domains) and 
UIM region (which binds ubiquitinated GGA3) to facilitate its 
sorting to lysosomes. It is interesting that two of the three PY 
motifs in LAPTM5 are also conserved in LAPTM4α and -β, 
but it is not yet known whether they also contribute to lyso-
somal targeting in these proteins.
Based on our work here, we propose that Nedd4 plays 
a crucial role in targeting LAPTM5 to lysosomes because a 
  mutant that cannot bind Nedd4 (LAPTM5-3YA) is retained in 
the Golgi, and knockdown of Nedd4 leads to the same Golgi-
  retention defect. Interestingly, although Nedd4 can ubiquitinate 
LAPTM5, LAPTM5 ubiquitination is not essential for its sort-
ing because the ubiquitination-impaired LAPTM5-10KR mu-
tant can still bind GGA3 and be sorted to lysosomes. This 
suggests that LAPTM5 ubiquitination may have other, yet un-
known, function, perhaps recruiting other proteins that contain 
ubiquitin-binding domains, enhancing function of the UIM, or 
regulating LAPTM5 stability. In contrast, GGA3 cannot bind 
the LAPTM5-3YA mutant, and this mutant is retained in the 
Golgi, suggesting that GGA3 can only interact with LAPTM5 
in the presence of Nedd4. Moreover, this interaction requires 
the presence of active Nedd4, because overexpression of a cata-
lytically inactive Nedd4(CS) precludes the association of GGA3 
with the Nedd4–LAPTM5 complex. Exactly how Nedd4 regu-
lates the interaction between LAPTM5 and GGA3 is currently 
unknown, but it is intriguing that the presence of active Nedd4 is 
required for the LAPTM5-UIM to more strongly bind ubiquitin. 
Thus, it is possible that Nedd4 binding to LAPTM5 ensures 
that the UIM of LAPTM5 can properly bind ubiquitinated 
GGA3 (Fig. 10). Moreover, we show that Nedd4 is also able to 
ubiquitinate GGA3, thereby further promoting the association 
of GGA3 with the LAPTM5-UIM.
Based on our observation that GGA3 bearing a muta-
tion in its GAT domain, GGA3-L276A (which we show cannot 
bind ubiquitin), is still able to interact with LAPTM5, we be-
lieve that ubiquitination of LAPTM5 is not required for GGA3 
binding, an observation that is in accord with our fi  ndings of 
proper lysosomal sorting of LAPTM5 lacking its ubiquitina-
tion sites. Thus, our work describes a novel mode of recruiting 
GGA3 to a protein complex in the Golgi; an interaction of ubiq-
uitinated GGA3 with the UIM of LAPTM5 (Fig. 10). Moreover, 
this recruitment involves the ubiquitin ligase Nedd4,   placing 
this E3 ligase in a complex with GGA3. Although we do 
not know which physiological E3 ligases are responsible for 
GGA3 ubiquitination, we show here that Nedd4 can ubiqui-
tinate GGA3 in cells, suggesting that Nedd4 may be one such 
E3 ligase.
Our observation of the abolishment of binding of the 
GGA3-GAT domain mutant L276A to ubiquitin, although in 
agreement with previous work (Puertollano and Bonifacino, 
2004; Shiba et al., 2004), is at odds with recent reports  (Kawasaki 
et al., 2005; Prag et al., 2005) that demonstrate, using structural 
determinations, that a second site (site 1) in the GAT domain of 
GGA3 provides stronger affi  nity of interactions with ubiquitin 
than site 2, to which L276 belongs. As discussed elsewhere 
(Prag et al., 2005), ubiquitin binding is strongly affected by the 
mode of presentation and by the oligomerization state of its 
  interacting partners, which could provide a possible explanation 
for the discrepant results.
It had been previously documented that the presence of 
the UIM in several endocytic proteins (e.g., epsin, eps15, Hrs) 
not only allows binding of ubiquitin to the UIM itself, but also 
promotes ubiquitination of these proteins on regions outside the 
UIM (Katz et al., 2002; Polo et al., 2002). Moreover, this ubiq-
uitination often involves Nedd4 family members. However, it is 
not known how Nedd4 proteins are recruited to proteins such as 
epsin, eps15, or Hrs, which do not possess PY motifs. In the 
case of LAPTM5, we show here that it contains both UIM and 
PY motifs, allowing it to directly bind Nedd4, to become ubiq-
uitinated by Nedd4, and to bind ubiquitin (attached to GGA3) 
Figure 10.  A model depicting the role of Nedd4 and 
GGA3 in sorting of LAPTM5 to the lysosome from the 
Golgi. LAPTM5, via its PY motifs, binds (to the WW do-
mains of) Nedd4, permitting the UIM of LAPTM5 to bind 
ubiquitinated GGA3. Nedd4 may contribute to the ubiq-
uitination of GGA3. Thus, Nedd4 promotes the recruit-
ment of GGA3 to LAPTM5, allowing LAPTM5 translocation 
from the Golgi to the lysosome with the aid of GGA3. 
After Nedd4-mediated ubiquitination, Nedd4 may disso-
ciate, leaving the GGA3–LAPTM5 complex to sort into 
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via its UIM. GGA3 itself was recently shown to become mono-
ubiquitinated (Shiba et al., 2004).
As already stated, the function of LAPTM5 is, thus far, 
unknown. Given its selective expression in immune cells and its 
lysosomal localization and similarities to LAPTM4 proteins, it 
is tempting to speculate that it may be involved in lysosomal 
movement in immune cells, and possibly in transport of mole-
cules destined to be released from the lysosome once at the 
plasma membrane.
Materials and methods
Constructs and antibodies
HA-LAPTM5 was inserted into pCDNA3. To generate DsRed-LAPTM5, 
LAPTM5 cDNA was cloned into the pDsRed C1 vector (Invitrogen) down-
stream of and in frame with the DsRed ﬂ  uorescent protein coding sequence. 
Mutations in LAPTM5, depicted in Fig. 1, were generated by site-directed 
mutagenesis using PCR, veriﬁ   ed by sequencing and subcloned into 
pCDNA3. GST-WW2 constructs were previously described (Staub et al., 
1996). His-tagged ubiquitin construct was obtained from D. Bohmann 
  (University of Rochester Medical Center, Rochester, NY; Treier et al., 1994) 
and Myc-tagged WT and mutant GGA3 (L276A) were provided by 
J.   Bonifacino (National Institutes of Health, Bethesda, MD). To knock down 
Nedd4-1, the oligo G  A  T  G  A  A  G  C  C  A  C  C  A  T  G  T  A  T  A   was synthesized and in-
serted into the pSUPER-EGFP vector, as previously described (Amsen et al., 
2006). For GGA3 knockdown, the oligo A  A  A  C  G  G  C  T  T  C  C  G  C  A  T  C  C  T  C   
was used as reported earlier (Puertollano and Bonifacino, 2004) and in-
serted into the pSUPER-EGFP as previously described (Amsen et al., 2006). 
Polyclonal antibody against LAPTM5 was generated using GST fusion pro-
teins containing the C terminus of LAPTM5 (amino acid sequence between 
225 and 260). Polyclonal anti–Nedd4-Hect domain antibodies (speciﬁ  c 
for Nedd4-1) were described earlier (Staub et al., 1997). Anti–Nedd4-2 
antibodies were generated against a GST fusion protein encompassing a 
regions that is unique to Nedd4-2. Both anti–Nedd4-1 and -2 antibodies 
were afﬁ  nity puriﬁ  ed before use. The anti-GGA3 antibody was obtained 
from Santa Cruz Biotechnology, Inc. Rabbit anti-HA antibody for immuno-
ﬂ  uorescence was purchased from Sigma-Aldrich.
Cell culture and transfections
HEK293T cells were maintained in DME supplemented with 10% fetal bo-
vine serum, 100 U/ml penicillin, and 100 μg/ml streptomycin. The cells 
were transfected using the calcium phosphate precipitation method.
The immature murine DC2.4 cells (Shen et al., 1997) provided by 
K. Rock (University of Massachusetts Medical Center, Worcester, MA) were 
maintained in complete RPMI 1640 medium containing 10% fetal bovine 
serum, 2 mM L-glutamine, 100 μM nonessential amino acids, 100 U/ml 
penicillin, 100 μg/ml streptomycin, and 50 μM β-mercaptoethanol. Trans-
fections were performed using ESCORT V transfection reagent (Sigma-
  Aldrich) according to the manufacturer’s protocol.
Immunoﬂ  uorescent confocal microscopy
Autoﬂ  uorescent DsRed-LAPTM5 was visualized using ﬂ  uorescent confocal 
microscopy (excitation maximum, 558 nm; emission maximum, 583 nm). 
To visualize the plasma membrane, the HEK293T cells were stained with 
Alexa Fluor 488–conjugated concanavalin A (Invitrogen). The cells were 
ﬁ  xed at varying times after transfection using partial Shaudinn’s ﬁ  xative 
(one part 95% ethanol/two parts saturated mercuric chloride) followed by 
wash in 70% methanol or 4% paraformaldehyde in PBS, followed by 
0.1% Triton X-100. Fixed cells were incubated with the appropriate serum 
to block nonspeciﬁ  c antibody binding. To visualize Golgi and lysosomes, 
the cells were stained with polyclonal antibody against giantin (1:750; 
Covance) and H4A3 monoclonal antibody against LAMP1 (1:1,000; De-
velopmental Studies Hybridoma Bank, under NICHD auspices; University 
of Iowa), followed by Cy5-conjgugated (Jackson ImmunoResearch Labora-
tories) or Alexa Fluor 647–conjugated (Invitrogen) anti–rabbit or anti–
mouse secondary antibodies, respectively. To visualize early, sorting, and 
recycling endosomes, we used anti-EEA1 (Abcam), Hrs (H. Stenmark, The 
Norwegian Radium Hospital, Oslo, Norway), and Rab11 (Zymed) anti-
bodies, respectively (each at 1:250 dilution). Single-plane images were 
acquired with a LSM 510 confocal microscope under 63×, 1.4 NA, oil-
immersion objective (Carl Zeiss MicroImaging, Inc.). Fluorescent intensity 
was quantiﬁ  ed with the LSM510 v3.2 ImagePC software (Carl Zeiss Mi-
croImaging, Inc.). To better visualize colocalization of proteins, the Cy5/
Alexa Fluor 647 and Alexa Fluor 488 were reassigned into green and 
blue colors, respectively.
DC2.4 cells were ﬁ   xed with 4% paraformaldehyde in PBS and 
  permeabilized with 0.1% Triton X-100. Fixed cells were incubated 
with appropriate sera to block nonspeciﬁ  c antibody binding. To visualize 
Golgi and lysosomes, the cells were stained with polyclonal antibody 
against   giantin (1:250; Covance) and monoclonal rat CD107a antibody 
against  LAMP1 (1:750; BD Biosciences), followed by Cy5-conjugated 
anti–rabbit or anti–rat secondary antibodies (Jackson ImmunoResearch 
Laboratories), respectively.
Immunogold labeling and EM
Cryosectioning and immunolabeling were performed as previously de-
scribed (Folsch et al., 2001), with the following changes. 24 h after trans-
fection, cells were ﬁ   xed for 1 h in 4% paraformaldehyde, followed by 
overnight ﬁ  xation in 8% paraformaldehyde. 75-nm-thick sections were col-
lected on formvar-coated nickel grids, at −120°C. The grids were blocked 
in a solution of 5% ﬁ  sh skin gelatin for 30 min and incubated with mouse 
anti-HA antibodies (1:25) and either rat CD107a (1:20) or rabbit LAMP2 
(1:20; Sigma-Aldrich), giantin/furin (1:20; Abcam), or GGA3 (1:40; 
  Abcam), followed by ﬁ  ve washes in PBS and appropriate combination of 
6 nm goat anti–mouse IgG/IgM and 10 nm goat anti–rabbit IgG, or with 
15 nm goat anti–rat IgG (1:20; Electron Microscopy Sciences). The   images 
were taken using a transmission EM (Tecnai 20; FEI) at 80 kV equipped 
with a camera (Dualview; Gatan), and processed using acquisition soft-
ware (DigitalMicrograph; Gatan).
Pull-down and coIP assays
HEK293T (or DC2.4 cells) cells expressing either WT or mutant LAPTM5 
cells were lysed with 1 ml of lysis buffer (50 mM Hepes, pH 7.5, 150 mN 
NaCl, 1% Triton X-100, 10% glycerol, 1.5 mM MgCl2, 1.0 mM EGTA, 
10 mg/ml leupeptin, 10 mg/ml aprotinin, and 1 mM PMSF) and cleared 
by centrifugation at 14,000 rpm for 10–20 min. The cleared supernatants 
were used for pull-down and coIP experiments. For pull-down experiments, 
500 μg of cell lysates were incubated with 50 μg GST or GST-Nedd4-
WW2 (GST-WW2) protein on glutathione–Sepharose beads for 2 h at 
4°C. Beads were washed twice with 1 ml HNTG (20 mM Hepes, pH 7.5, 
150 mM NaCl, 10% glycerol, and 0.1% Triton X-100) and twice with lysis 
buffer. Bound proteins were eluted from the bead with 1× SDS-PAGE sam-
ple buffer, resolved by SDS-PAGE, and transferred to nitrocellulose mem-
brane. Bound LAPTM5 was identiﬁ  ed with anti-HA antibody (1:10,000; 
Babco), followed by secondary antibodies and ECL detection (GE Health-
care). To analyze the ability of the UIM of LAPTM5 to bind ubiquitin, 500 μg 
HEK293T cell lysates expressing either WT or mutant LAPTM5 that lacks 
the UIM (LAPTM5-UIMm) were incubated with ubiquitin immobilized on 
protein G beads (pro-G-Ub; 20 μg), the beads were washed, and bound 
LAPTM5 was detected with anti-HA antibody. For coIPs, HEK293T cell ly-
sates expressing transfected WT or mutant HA-LAPTM5 together with T7-
Nedd4 (CS; 500 μg each) were incubated with anti-T7 antibody for 1 h at 
4°C, followed by the addition of 10 μl of protein G–Sepharose for an ad-
ditional 1 h. After bound proteins were washed with lysis buffer (two times) 
and HNTG (three times), the coimmunoprecipitated LAPTM5 proteins were 
detected with anti-HA antibody (1:10,000). To identify GGA3 in the 
Nedd4–LAPTM5 complex, HEK293T cells were transfected with T7-Nedd4 
(WT or CS mutant), Myc-GGA3 (WT or the L276A mutant that cannot bind 
ubiquitin) and HA-LAPTM5, and their lysates were subjected to IP with 
HA (LAPTM5) antibodies and immunoblotting with anti-Myc antibody 
(1:10,000) to detect bound GGA3.
Ubiquitination assays
HEK293T cells were cotransfected with HA-LAPTM5 or DsRed-LAPTM5 
(WT or mutants) and His-tagged ubiquitin (His-Ub), and where indicated, 
cells were also cotransfected with T7-tagged Nedd4 (WT or catalytically 
inactive CS mutant). Cells were lysed in lysis buffer supplemented with 50 μM 
LLnL (N-acetyl-Leu-Leu-norleucinal; Sigma-Aldrich). Ubiquitinated (histidinated) 
proteins were then precipitated with Ni–Agarose beads for 4 h at 4°C and 
blotted with anti-HA antibodies to detect ubiquitinated LAPTM5, or where 
applicable, with anti-GGA3 antibodies to detect ubiquitinated GGA3. 
To ensure ubiquitination of LAPTM5, and not of associated proteins, the 
cell lysates were treated with 1% SDS and boiled for 5 min. These boiled 
lysates were then diluted 11 times with lysis buffer to dilute the SDS before 
their use in the Ni-bead precipitation step. Complexes with Ni–Agarose 
bead were washed with lysis buffer (two times) and HNTG (three times) JCB • VOLUME 175 • NUMBER 4 • 2006  644
and immunoblotted with anti-HA antibodies to detect LAPTM5, followed 
by anti–mouse horseradish peroxidase secondary antibodies and ECL 
  detection. Equal amounts of different lysates ( 2 mg) were used for 
the precipitations.
Online supplemental material
Fig. S1 describes the contribution of the individual PY motifs of LAPTM5 to 
binding to Nedd4 and to LAPTM5 ubiquitination. Fig. S2 shows lack of co-
localization of LATPM5(3YA) with EEA1, Rab11, or Hrs. Fig. S3 shows lyso-
somal localization of HA-tagged LAPTM5(10KR). Fig. S4 shows endogenous 
expression of LAPTM5 in DC2.4 cells. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200603001/DC1.
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